Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ovarian cancer, five-year stage-specific relative survival rates (2004-2008).

Literature DB >> 21852260

Ovarian cancer, five-year stage-specific relative survival rates (2004-2008).

Abstract

Entities: Disease

Mesh：

Year: 2011 PMID： 21852260 DOI： 10.1093/jnci/djr342

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition.

Authors: Lin Deng; Ding-Qing Feng; Bin Ling
Journal: J Zhejiang Univ Sci B Date: 2020 Apr. Impact factor: 3.066

2. MicroRNA-126 affects ovarian cancer cell differentiation and invasion by modulating expression of vascular endothelial growth factor.

Authors: Jianqiao Luo; Caidan Zhu; Hongya Wang; Li Yu; Jianwei Zhou
Journal: Oncol Lett Date: 2018-02-12 Impact factor: 2.967

3. Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis.

Authors: C S Park; T-K Kim; H G Kim; Y-J Kim; M H Jeoung; W R Lee; N K Go; K Heo; S Lee
Journal: Oncogene Date: 2016-01-25 Impact factor: 9.867

4. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.

Authors: Ting-Yu Lin; Wei-Lin Huang; Wei-Yu Lee; Ching-Wei Luo
Journal: PLoS One Date: 2015-08-28 Impact factor: 3.240

Review 5. The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.

Authors: Chaoyang Sun; Na Li; Dong Ding; Danhui Weng; Li Meng; Gang Chen; Ding Ma
Journal: PLoS One Date: 2014-05-01 Impact factor: 3.240

6. Primary ovarian carcinomas and abdominal metastasis contain 4,6-disulfated chondroitin sulfate rich regions, which provide adhesive properties to tumour cells.

Authors: Myrtille J E Vallen; Samuel Schmidt; Arie Oosterhof; Johan Bulten; Leon F A G Massuger; Toin H van Kuppevelt
Journal: PLoS One Date: 2014-11-05 Impact factor: 3.240

Ovarian cancer, five-year stage-specific relative survival rates (2004-2008).

1. Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition.

2. MicroRNA-126 affects ovarian cancer cell differentiation and invasion by modulating expression of vascular endothelial growth factor.

3. Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis.

4. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.

Review 5. The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.

6. Primary ovarian carcinomas and abdominal metastasis contain 4,6-disulfated chondroitin sulfate rich regions, which provide adhesive properties to tumour cells.

7. Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study.

8. miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27^kip1.

9. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.

10. A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma.